Markets
Sports-betting
(Samuel Corum/Getty Images)

Today’s sports-betting boom may be tomorrow’s investment issue

It’s splashed on the outfield fences. Emblazoned at center court in the college basketball game. On the digital billboard behind the goal posts. And, of course, in the celebrity-filled ads packed into every commercial break. Sports betting is everywhere.

Since 2018, when the US Supreme Court effectively said states could legalize sports betting, the size of the legal market has ballooned from nearly nothing to the $120 billion in sports bets Americans made last year.

So yeah, people seem to like betting, or at least companies like Flutter Entertainment — owner of FanDuel — DraftKings, Caesars Entertainment and MGM Resorts have cracked the code on getting people to hand over their money.

And state governments, which rushed to enact laws legalizing sportsbooks, now have a juicy, new, growing source of tax revenue.

What’s not to love?

Well, likely a lot, which is becoming increasingly clear as academics dig into the data this national wagering experiment has started to produce.

To wit, a recent paper was published by a group of academics who wanted to know if over the long-term, sports betting — rather than just substituting for other forms of entertainment spending — would start to eat into savings and investment, eroding household financial stability.

To find out, they scoured transaction-level data from over 230,000 households provided by a financial-data firm. The data included information on purchases, after tax investments at brokerages and transfers to online betting sites. Then they looked at what happened as 26 states legalized sports betting between 2018 and 2023, the time span their data covered. They analyzed the numbers to see how financial behavior changed as sports betting came online in a state. They found:

“Betting activity crowds out financial investments, leading to a reduction in net deposits to brokerage accounts, including robo-advisors that are primarily used for long-term savings. This substitution is particularly pronounced among financially constrained households. Additionally, consumption in complementary entertainment-related categories rises, likely reflecting spillovers from increased sports betting. Combined, the increase in betting and associated consumption leads to heightened financial instability as households run-up credit card balances and more frequently overdraw their bank accounts."

Some of the biggest impacts of sports gambling was the way it seemed to eat into investment in stocks over time, especially for households with little savings.

Upon the introduction of legalized gambling, there was an especially sharp drop relative to the mean of 41% in investment — essentially they were looking at transfers to online brokerage accounts — for households that had lower savings. In other words, before phone-based sports gambling was introduced, households were likely put a bit of cash into an online brokerage each month. After gambling was legalized, that tended to change.

“The money that you would have been putting into your Schwab account or Fidelity or whatever is now going into online sports betting where we know, in aggregate, people are losing it,” said Justin Balthrop, an assistant professor of finance at the University of Kansas and one of the authors of the paper.

The economists wanted to be sure those bettors weren’t just substituting sports bets for gambling-like speculative trades, such as buying zero-day call options or crypto.

But they found that even when they restricted their analysis to so-called robo-advisor brokerage firms that specialize in fairly tame investments in index funds, the outcome was the same.

Just to be clear, the authors could only look at after tax stock market investment, not 401k contributions, which might mean it doesn’t give a full picture of household investment activity. And, of course, it’s just one paper.

But it’s part of a growing literature. For instance, this paper, put out in October, found that as states legalized sports gambling they saw “a substantial increase in bankruptcy rates, debt collections, debt consolidation loans, and auto loan delinquencies.”

Balthrop, who says he’s done a bit of sports gambling himself, stressed that tends to be libertarian in his view. But he thinks the paper could give policymakers some important data they could use to assess the full impact of sports gambling.

“I don’t want to restrict people’s access to things. I think that it is not the central government’s job to solve all problems. But one way that you create a future society that has less dependency on centralized aid is you incentivize people to save and invest productively for their future,” he said.

“But if people stop doing that altogether and instead want to bet on the Super Bowl, well, we’re going to wind up 30 years from now and no one’s going to have any money,” he continued. “I’m being aggressive. But that’s the trend we want to at least identify before it gets out of hand.”

More Markets

See all Markets
markets

Trump administration says tariffs on Chinese semiconductor imports are coming... in 2027

After a year-long investigation into China’s tactics to bolster its domestic semiconductor industry, the US has determined that its practices are “unreasonable” and is going to do something about that in 18 months.

The Trump administration’s office of the US trade representative said today that it plans to impose tariffs on imports of Chinese semiconductors at a rate higher than 0% to be decided at least 30 days before June 23, 2027.

“China’s pursuit of its dominance goals has severely disadvantaged US companies, workers, and the U.S. economy generally through lessened competition and commercial opportunities and through the creation of economic security risks from dependencies and vulnerabilities,” per the USTR’s notice of action.

These levies, should they come to pass, would apply to silicon, diodes, transistors, and more.

US markets were completely unbothered by this revelation, likely because there is no immediate action against Chinese semi companies and therefore no disruption to business-as-usual. This represents a punting of a contentious matter, similar to how China delayed restrictions on rare earth shipments as part of a deal between Presidents Trump and Xi following their October meeting.

It’s another sign of a thaw in the US-China relations over the hot-button issue of semiconductors after President Trump gave Nvidia the go-ahead to sell its H200 chips to buyers in the world’s second-largest economy.

markets

ServiceNow strikes deal to buy cybersecurity firm Armis for $7.75 billion in cash

ServiceNow has agreed to acquire cybersecurity startup Armis for $7.75 billion in an all-cash deal, the largest purchase in the company's history.

That price tag is $750 million above what Bloomberg suggested was the top end of what Armis would cost just last week, and about $1.65 billion above what the company had been valued at in a November funding round.

Armis had been readying itself for an IPO, with many major investors looking to take a stake in the firm.

Instead, it’s now a key cog in the software platform company’s bid to lean on cybersecurity features to bolster its appeal to customers in a world in which the rise of AI adds to the potential threats of business disruptions and data breaches.

Per the press release:

As rapid AI adoption expands the attack surface for organizations, real-time visibility into vulnerabilities and actionable insights for what to fix first are critical to minimize risk and strengthen security posture. The acquisition of Armis will extend and enhance ServiceNow’s Security, Risk, and OT portfolios in critical and fast-growing areas of cybersecurity and drive increased AI adoption by strengthening trust across businesses’ connected environments.

markets

Novo Nordisk rallies after FDA weight loss pill approval

Novo Nordisk’s US-listed shares are up 7% in pre-market trading on Tuesday after the US Food and Drug Administration approved its Wegovy weight loss pill on Monday evening.

Now the first pill of its kind to receive approval from the regulator, Novo’s Wegovy pill is expected to launch in the US in early January 2026, and awaits the European Medicines Agency and other regulatory authorities’ approval after submitting for review in the second half of 2025, per the company’s press release. The 1.5 milligram starting dose of the pill will be sold at an introductory price of $149 a month.

“The pill is here. With today's approval of the Wegovy® pill, patients will have a convenient, once-daily pill that can help them lose as much weight as the original Wegovy® injection,” said Mike Doustdar, president and CEO of Novo Nordisk.

The approval was based on Novo’s Oasis 4 trial, which found participants who took 25 milligram doses of Wegovy pills daily lost 16.6% of their body weight over a 64 week period.

The approval will give Novo — which lost more than 50% of its market cap this year after Eli Lilly took the crown in weekly US prescriptions for injectable weight-loss drugs with its product Zepbound — a first-mover advantage in the expanding market. Lilly, which is down some 1% in pre-market trading today, has said its own oral drug orforglipron could be approved by March 2026.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.